 Oxford Immunotec Global PLC OXFD the Company, a global, high-growth diagnostics company, today announces the release of the T-SPOT Discovery SARS-CoV-2 test kit. This research kit could make a significant contribution towards development of a new tool to manage the COVID-19 pandemic, which in turn could help to bring nations out of their current lockdowns in a faster, safer and more controlled manner. T-SPOT Discovery SARS-CoV-2 builds on Oxford Immunotecs experience with TB diagnosis and the assessment of immune response to CMV in transplant patients, to apply the Companys established, proprietary T-SPOT technology to the fight against COVID-19. 